235 related articles for article (PubMed ID: 25132446)
21. A clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: A single tertiary care pediatric institution experience in North America.
Coffey AM; Lewis A; Marcogliese AN; Elghetany MT; Punia JN; Chang CC; Allen CE; McClain KL; Gaikwad AS; El-Mallawany NK; Curry CV
Pediatr Blood Cancer; 2019 Aug; 66(8):e27798. PubMed ID: 31099136
[TBL] [Abstract][Full Text] [Related]
22. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
[No Abstract] [Full Text] [Related]
23. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
[TBL] [Abstract][Full Text] [Related]
24. Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients.
Merlino C; Cavallo R; Bergallo M; Giacchino F; Bollero C; Negro Ponzi A; Cavallo G
New Microbiol; 2003 Apr; 26(2):141-9. PubMed ID: 12737195
[TBL] [Abstract][Full Text] [Related]
25. A case of hemophagocytic lymphohistiocytosis after the primary Epstein-Barr virus infection.
Kitazawa Y; Saito F; Nomura S; Ishii K; Kadota E
Clin Appl Thromb Hemost; 2007 Jul; 13(3):323-8. PubMed ID: 17636196
[TBL] [Abstract][Full Text] [Related]
26. [Two young adult cases of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis with monoclonal proliferation of virus-infected cells within a short period after primary infection].
Idutsu K; Abe Y; Matsushima T; Sada E; Ohtsuka R; Kiyasu J; Shiratsuchi M; Kotoh K; Nishimura J; Ohga S; Takayanagi R
Rinsho Ketsueki; 2008 Nov; 49(11):1541-7. PubMed ID: 19047785
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults.
Wang Z; Kimura S; Iwasaki H; Takase K; Oshiro Y; Gamachi A; Makihara K; Ogata M; Daa T; Momosaki S; Takamatsu Y; Takeshita M
Diagn Pathol; 2021 Jun; 16(1):48. PubMed ID: 34088321
[TBL] [Abstract][Full Text] [Related]
28. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands.
Seliem RM; Griffith RC; Harris NL; Beheshti J; Schiffman FJ; Longtine J; Kutok J; Ferry JA
Am J Surg Pathol; 2007 Sep; 31(9):1439-45. PubMed ID: 17721201
[TBL] [Abstract][Full Text] [Related]
29. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
[TBL] [Abstract][Full Text] [Related]
30. Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.
Calabrese F; Loy M; Lunardi F; Marino D; Aversa SM; Rea F
Transpl Infect Dis; 2010 Aug; 12(4):342-6. PubMed ID: 20030794
[TBL] [Abstract][Full Text] [Related]
31. Early intervention in post-transplant lymphoproliferative disorders based on Epstein-Barr viral load.
Hoshino Y; Kimura H; Kuzushima K; Tsurumi T; Nemoto K; Kikuta A; Nishiyama Y; Kojima S; Matsuyama T; Morishima T
Bone Marrow Transplant; 2000 Jul; 26(2):199-201. PubMed ID: 10918431
[TBL] [Abstract][Full Text] [Related]
32. Quantification of Epstein-Barr virus DNA is helpful for evaluation of chronic active Epstein-Barr virus infection.
Sakamoto Y; Mariya Y; Kubo K
Tohoku J Exp Med; 2012 Aug; 227(4):307-11. PubMed ID: 22850617
[TBL] [Abstract][Full Text] [Related]
33. [Clinical features and laboratory findings of adult Epstein-Barr virus associated T/NK lymphoproliferative disease].
Zhang Q; Zhang HY; Zhang WL; Zhong FL; Feng J; Meng QX; Yin WH; Nie LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):953-7. PubMed ID: 23998592
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr Virus (EBV)-induced B-cell Lymphoproliferative Disorder Mimicking the Recurrence of EBV-associated Hemophagocytic Lymphohistiocytosis.
Yatsushiro Y; Nishikawa T; Saito A; Nakazawa Y; Imadome KI; Nakagawa S; Kodama Y; Okamoto Y; Kanegane H; Kawano Y
J Pediatr Hematol Oncol; 2019 Jan; 41(1):e44-e46. PubMed ID: 29324572
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus serology and PCR: conflicting results in an immunocompetent host. A case report and review of literature.
Cattoir L; Van Hende V; De Paepe P; Padalko E
Acta Clin Belg; 2014 Aug; 69(4):262-6. PubMed ID: 24916751
[TBL] [Abstract][Full Text] [Related]
36. Peripheral T-cell lymphoma with progression to a clonally related, Epstein Barr virus+, cytotoxic aggressive T-cell lymphoma: evidence for secondary EBV infection of an established malignant T-cell clone.
Langer R; Geissinger E; Rüdiger T; von Schilling C; Ott G; Mandl-Weber S; Quintanilla-Martinez L; Fend F
Am J Surg Pathol; 2010 Sep; 34(9):1382-7. PubMed ID: 20739840
[TBL] [Abstract][Full Text] [Related]
37. TEN-like eruption in setting of EBV positive T-cell lymphoproliferative disease with HLH, in a child.
Sharma N; Clark J; Pham H; Efron D; MacGregor D; O'Keefe R; Orchard D
Australas J Dermatol; 2014 Aug; 55(3):e44-7. PubMed ID: 23573996
[TBL] [Abstract][Full Text] [Related]
38. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus-associated T cell lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin's disease.
Yufu Y; Kimura M; Kawano R; Noguchi Y; Takatsuki H; Uike N; Ohshima K
Bone Marrow Transplant; 2000 Dec; 26(12):1339-41. PubMed ID: 11223975
[TBL] [Abstract][Full Text] [Related]
40. Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hosts.
Ng SB; Ohshima K; Selvarajan V; Huang G; Choo SN; Miyoshi H; Wang S; Chua HC; Yeoh AE; Quah TC; Koh LP; Tan PL; Chng WJ
Orphanet J Rare Dis; 2014 Dec; 9():165. PubMed ID: 25475054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
